This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Newtown, PA (US) (2016)
- Princeton, NJ (US) (2019)
Company Filing History:
Years Active: 2016-2019
Title: Wendy L Trigona: Innovator in Antibody Therapeutics
Introduction
Wendy L Trigona is a prominent inventor based in Princeton, NJ (US). She has made significant contributions to the field of antibody therapeutics, particularly in the treatment of inflammatory diseases. With a total of 2 patents, her work has the potential to impact many patients suffering from various conditions.
Latest Patents
Wendy's latest patents include a method of using antibody polypeptides that antagonize CD40 to treat inflammatory bowel disease (IBD). This innovative method involves the administration of an antibody polypeptide that specifically binds to a novel epitope of human CD40, without exhibiting CD40 agonist activity. Additionally, she has developed a patent for IP-10 antibody dosage escalation regimens. This method provides a systematic approach to treating IP-10-related diseases by adjusting the dosage of an anti-IP-10 antibody based on the subject's antibody levels.
Career Highlights
Wendy L Trigona is associated with Bristol-Myers Squibb Company, where she continues to advance her research in antibody therapies. Her work is characterized by a commitment to improving treatment options for patients with complex medical conditions.
Collaborations
Wendy collaborates with notable colleagues, including Marek Honczarenko and Vaishali Shah, to further enhance the development of innovative therapeutic solutions.
Conclusion
Wendy L Trigona's contributions to the field of antibody therapeutics exemplify her dedication to medical innovation. Her patents and ongoing research hold promise for improving treatment strategies for patients with inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile